First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811

Future Oncology, Ahead of Print.

Source: Future Oncology - November 10, 2020 Category: Cancer & Oncology Authors: Hyun Cheol Chung Yung-Jue Bang Charles S  Fuchs Shu-Kui Qin Taroh Satoh Kohei Shitara Josep Tabernero Eric van Cutsem Maria Alsina Zhu  Alexander Cao Jia Lu Pooja Bhagia Chie-Schin Shih Yelena Y Janjigian Source Type: research